loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 202710 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CLARITHROMYCIN (2)

filter

01 STRIDES PHARMA (2)

filter

01 TABLET;ORAL (2)

filter

01 250MG (1)

02 500MG (1)

filter

01 USA (2)

TABLET;ORAL
500MG
CLARITHROMYCIN
USA
202710
2013-06-10
RX
TABLET;ORAL
250MG
CLARITHROMYCIN
USA
202710
2013-06-10
RX

Looking for CTD TGA MCC DOSSIER APPLICATION 202710

Looking for CTD TGA MCC DOSSIER APPLICATION 202710 2

19

Strides Pharma Science, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

One of their notable products is CLARITHROMYCIN, with a corresponding application number 202710 and regulatory information .

proudly manufactured in the

approval since 2013-06-10

Strides Pharma Science's CLARITHROMYCIN TABLET;ORAL, medication with 500MG of CLARITHROMYCIN.

18

Strides Pharma Science, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

One of their notable products is CLARITHROMYCIN, with a corresponding application number 202710 and regulatory information .

proudly manufactured in the

approval since 2013-06-10

Strides Pharma Science's CLARITHROMYCIN TABLET;ORAL, medication with 250MG of CLARITHROMYCIN.

Post Enquiry
POST ENQUIRY